Budge James 4

What Happened
James Budge, Chief Financial Officer of Hinge Health (HNGE), sold a total of 5,907 shares in three open‑market transactions on May 26, 2026, generating about $317,757 in proceeds. The individual sales were: 3,507 shares at a weighted average price of $53.32 ($187,006), 2,100 shares at $54.37 ($114,184), and 300 shares at $55.22 (~$16,567). These were sales (not purchases), which are often routine insider liquidity events.

Key Details

• Transaction date: 2026-05-26; Form 4 filed 2026-05-27 (timely filing).
• Shares sold: 3,507 @ $53.32 (weighted avg; range $52.88–$53.85), 2,100 @ $54.37 (range $53.88–$54.86), 300 @ $55.22 (range $55.05–$55.36).
• Total shares sold: 5,907; total proceeds: ≈ $317,757.
• Footnote: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted June 12, 2025. Reporting person will provide breakdown of quantities at each price within the ranges upon request.
• Shares owned after the transaction: not disclosed in the filing.

Context
These were open‑market sales under a prearranged 10b5‑1 plan, a common mechanism executives use to sell shares on a set schedule. Such sales are generally viewed as liquidity management rather than a directional signal about company prospects; purchases tend to be more informative about insider conviction.